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Objective: Automatic monitoring of Adverse Drug Reactions (ADRs), deﬁned as adverse patient outcomes
caused by medications, is a challenging research problem that is currently receiving signiﬁcant attention
from the medical informatics community. In recent years, user-posted data on social media, primarily
due to its sheer volume, has become a useful resource for ADR monitoring. Research using social media
data has progressed using various data sources and techniques, making it difﬁcult to compare distinct
systems and their performances. In this paper, we perform a methodical review to characterize the
different approaches to ADR detection/extraction from social media, and their applicability to
pharmacovigilance. In addition, we present a potential systematic pathway to ADR monitoring from
social media.
Methods: We identiﬁed studies describing approaches for ADR detection from social media from the
Medline, Embase, Scopus and Web of Science databases, and the Google Scholar search engine. Studies
that met our inclusion criteria were those that attempted to extract ADR information posted by users
on any publicly available social media platform. We categorized the studies according to different char-
acteristics such as primary ADR detection approach, size of corpus, data source(s), availability, and evaluation
criteria.
Results: Twenty-two studies met our inclusion criteria, with ﬁfteen (68%) published within the last two
years. However, publicly available annotated data is still scarce, and we found only six studies that made
the annotations used publicly available, making system performance comparisons difﬁcult. In terms of
algorithms, supervised classiﬁcation techniques to detect posts containing ADR mentions, and lexicon-
based approaches for extraction of ADR mentions from texts have been the most popular.
Conclusion: Our review suggests that interest in the utilization of the vast amounts of available social
media data for ADR monitoring is increasing. In terms of sources, both health-related and general social
media data have been used for ADR detection—while health-related sources tend to contain higher pro-
portions of relevant data, the volume of data from general social media websites is signiﬁcantly higher.
There is still very limited amount of annotated data publicly available , and, as indicated by the promising
results obtained by recent supervised learning approaches, there is a strong need to make such data avail-
able to the research community.
 2015 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Harmful reactions that are caused by the intake of medication
are known as Adverse Drug Reactions (ADRs) and the activities
relating to the detection, assessment, understanding and preven-
tion of adverse effects attributable to prescription drugs arereferred to as pharmacovigilance [1]. Pharmacovigilance begins
during clinical trials and continues after the drug is released into
the market. Due to the various limitations of clinical trials, it is
not possible to fully assess the consequences of the use of a par-
ticular drug before it is released [2]. Adverse reactions caused by
drugs following their release into the market is a major public
health problem: with deaths and hospitalizations numbering in
millions (up to 5% hospital admissions, 28% emergency visits, and
5% hospital deaths), and associated costs of about seventy-ﬁve bil-
lion dollars annually [3–5]. Thus, post-marketing surveillance of
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bodies such as the U.S. Food and Drug Administration (FDA), and
international organizations such as the World Health
Organization (WHO) [6].
Government agencies, like the FDA or the European Medicines
Agency (EMA), have expanded their pharmacovigilance efforts in
various ways. In the U.S., post marketing surveillance of drugs
occurs actively and passively. Methods to accomplish this include
Phase IV clinical trials, in addition to voluntary and mandatory
reporting through the FDA’s Adverse Event Reporting System
(FAERS), MedWatch, and the Institute of Safe Medication
Practices Medication Error Reporting System (MERP) [7]. The
MedWatch program, for example, allows the public (patients and
providers) to report ADRs which they suspect or observe [8].
While it is mandatory for manufacturers to report adverse events,
reporting by healthcare professionals and the public is voluntary.
Due to the voluntary nature of these systems, reporting and detec-
tion of adverse events may not be timely and is incomplete. Recent
research has exposed the various inadequacies of spontaneous
reporting systems, prompting researchers to explore additional
sources for ADR monitoring [9,2,10]. These systems, for example,
suffer from under-reporting, over-reporting of known ADRs,
incomplete data, duplicated reporting, and unspeciﬁed causal
links. Various additional techniques have been utilized for post-
marketing monitoring of ADRs, including retrospective chart
analysis, prospective surveillance, and information extraction from
electronic health records, clinical narratives and case reports.
These approaches have their own associated challenges. For exam-
ple, electronic health records generally face challenges associated
with the pervasiveness of confounding variables, and the deﬁnition
and ascertainment of exposures and outcomes [2]. Clinical narra-
tives present the problem of limited access, as typically, only
researchers afﬁliated with medical centers can access the data.
The rapid growth of electronically available health related
information, and the ability to process large volumes of them
automatically, using natural language processing (NLP) and
machine learning algorithms, have opened new opportunities for
pharmacovigilance that could address some of the above-
mentioned limitations.1.1. Relevance of social media to public health
One domain where data has grown by massive proportions in
recent years, and continues to grow, is social media. Social net-
works have seen an unprecedented growth in terms of users
worldwide (e.g., as of 11th July 2014, Twitter has over
645,750,000 users and grows by an estimated 135,000 users every
day, generating 9100 tweets per second1). A large population of
patients are actively involved in sharing and posting health related
information in social media and particularly health social networks
[12]. A recent survey by the Pew Research Center’s survey [11] has
elucidated the relevance of social media in modern day public
health, explaining that 34% of caregivers and 20% of patients read
or watch someone else’s commentary or experience online.
Additionally, 11% of caregivers and 6% of patients share experiences
and post questions online. Health related social networks, those
focusing speciﬁcally on issues related to health, have been attracting
many users. In such platforms (e.g., DailyStrength [13], MedHelp
[14]), users discuss their health-related experiences, including use
of prescription drugs, side effects and treatments. Users tend to
share their views with others facing similar problems/results, which
makes such social networks unique and robust sources of1 http://www.statisticbrain.com/twitter-statistics/. Accessed on: 26th August,
2014.information about health, drugs and treatments. Due to the emer-
gence of such platforms, and the abundance of data available
through them, research on public health monitoring, including
ADR monitoring, has focused on exploiting data from these sources
in recent times [15–17].
In terms of monitoring public health, this has included studying
smoking cessation patterns on Facebook [18], identifying user
social circles with common medical experiences (like drug abuse)
[19], and monitoring malpractice [20]. When different patients
that suffer from a common disease, or use a speciﬁc medication,
share information about their symptoms, treatments or drug out-
comes, this information can provide valuable clinical insights for
both patients and health-related industries that go beyond tradi-
tional communication methods [21]. Infectious/viral disease moni-
toring, speciﬁcally, can beneﬁt strongly from utilizing social media.
For example, traditional systems may miss new or rare events (like
a new viral outbreak), and lack the real time capabilities and demo-
graphic reach that social media can provide, including data from
people that may not access healthcare through formal channels
[22]. Although speciﬁc information about a single user may not
be available or usable for privacy reasons, various resources are
currently available to perform some demographic analysis with
social media data.2 Furthermore, over the last decade, a number of
social media based surveillance systems have been developed,
reviewed, and implemented locally, nationally, and globally [23].
Recent advances in ADR monitoring have seen signiﬁcant strides
towards the use of automatic NLP techniques for mining drugs and
associated reactions from social media. User posts in social media
contain information about treatment outcomes and provide early
access to reported ADRs that could be beneﬁcial for health and phar-
maceutical industries. The type and volume of ADR information that
social media makes available to the health industry may not be
easily obtainable by other means. This includes the ADRs experi-
enced by those with special conditions, such as patients with rare
diseases, pregnant/nursing women, elderly people or patients with
comorbidities who are usually excluded from clinical trials [24].
1.2. Social media from the perspective of regulatory authorities and
the industry
From the perspective of regulatory authorities, the intent of
mining social media is to obtain additional data from the general
public that may be used to supplement existing voluntary infor-
mation systems. For example, the Association of the British
Pharmaceutical Industry (ABPI) published a set of guidance notes
in 2013, which help researchers and stakeholders manage ADR
complaints on digital media [25]. Though the document was cre-
ated for information purposes only, rather than regulatory/legal
advice, it offers instructions on how to handle such ADR reports.
It clearly deﬁnes a minimal information set needed to report the
ADR, which includes an identiﬁable patient, suspect drug, adverse
event, and identiﬁable reporter. The contact details required for
the identiﬁable reporter are compatible with the social media
domain, and include emails or screen names. It also states that
this information should be collected ‘‘if possible,’’ which leaves
room for incomplete data [25]. The FDA has not yet published
explicit guidelines for social media based pharmacovigilance,
but it has issued regulations for publishing promotional material
[26] and risk/beneﬁt information [27] on social media. Despite
the absence of a formal guidance, ADRs from social media can
still be reported to the FDA. The minimum data set for an ADR
report to the FDA is the same as that for the ABPI. Moreover, a2 Some resources for demographic information analysis: http://text-
alytics.com/core/userdemographics-info, http://www.demographicspro.com/, http://
smallbiztrends.com/2013/04/research-twitter-followers-demographics.html.
3 http://www.ncbi.nlm.nih.gov/pubmed. Accessed: 6/10/2014.
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are reviewed like any other spontaneous reporting systems,
while acknowledging variability in the quality of the reports
submitted [28].
In addition to regulatory authorities, signals identiﬁed through
social media could be used by pharmaceutical manufacturers, the
healthcare system, or healthcare researchers to fulﬁll requirements
of mandatory reporting. While the intent of social media mining is
to provide early signals, it could potentially be used by the
interested parties to validate or reject signals that have arisen in
other reporting systems. Pharmaceutical manufacturers, such as
AstraZeneca, have considered the use of social media from an
industry perspective: focusing on manufacturers’ responsibilities
to provide accurate and quality information regarding drugs [29].
Because regulatory authorities and pharmaceutical manufacturers
play a role in public safety, both may utilize social media to fulﬁll
the safety mission.
1.3. Pros and cons of social media monitoring
Various pros and cons of using social media for automatic ADR
monitoring [30,31], and more generally, for public health monitor-
ing, have been mentioned in recent literature—a full discussion of
which is outside the scope of this paper. However, in this subsec-
tion, we brieﬂy outline the opportunities that social media pre-
sents, and the obstacles associated with its use for health-related
research.
As already mentioned earlier in this section, the size and growth
of data on social media is unparalleled. Recent advances in the data
processing capabilities of machines, and machine learning and NLP
research present the possibility of utilizing this massive data
source for a variety of purposes, including public health. The fact
that it is a direct source of users’ personal experiences makes it a
lucrative resource. According to Harpaz et al. [32], social media
offers new opportunities for public health monitoring due to the
availability of large amounts of data that is internet-based,
patient-generated, unsolicited, and up-to-date. The use of social
media for health-related and other tasks is, however, not without
drawbacks and difﬁculties. The drawbacks found when utilizing
the user generated content of social media may include issues with
the credibility, recency, uniqueness, frequency, and salience of the
data [33]. Abbasi and Adjeroh [33] demonstrate the potential
downside of each of these ﬁve points and the importance of select-
ing the right media channel for social media analytics. For example,
the authors discuss the potential low salience of Twitter because of
the short text limits. In addition to these general problems related
to the data generated within social media, there are difﬁculties and
challenges posed by the processing and extraction of relevant
information using NLP techniques. A frequently encountered chal-
lenge is due to the fact that the data is generated by consumers,
and they tend to use misspellings, non-medical, descriptive terms
to discuss health issues. This reduces a system’s ability to
automatically extract mentions of relevant concepts and map them
to suitable medical lexicons for further analysis [17,34,35].
Traditional NLP methods that are used on longer texts have proven
to be inadequate when applied to short texts, such as those found
in Twitter [36]. Thus, recent research tasks have focused on devel-
oping NLP tools speciﬁcally for data from social media [37]. Some
recent articles (e.g., [38–41]) have reported the imbalance that
exists in data coming from social media. Only a small proportion
of drug-associated data collected from social media tend to contain
information associated with ADRs. This results in problems associ-
ated with annotations, since large volumes of data need to be
annotated for the inclusion of sufﬁcient numbers of posts contain-
ing ADRs. This data imbalance issue is a major problem for super-
vised machine learning approaches, particularly because it is thesmaller class that is of primary interest for the research. While
access to users’ personal experiences with prescription drugs is
one of the key advantages of social media, automatic deter-
mination of true personal experiences is challenging. In addition
to these, there are also technical, policy, and privacy challenges
associated with the use of social media for pharmacovigilance, as
pointed out by Edwards and Lindquist [30].
In this paper, we present a methodical review, which we con-
ducted on studies that attempt to overcome some of the obstacles,
and detect/extract ADRs from social media data using NLP-based
techniques. The primary intent of this paper is to categorize the
studies across various dimensions such as primary aim, tech-
nique/algorithm, size of corpus, availability of data, and evaluation
technique. Despite the recent ﬂurry of work, there is no established
evaluation framework for ADR detection, neither is there a frame-
work to unify the common information from various research
efforts. Thus, we believe that a review, such as this, will provide
the necessary information to drive the development and evalua-
tion of future approaches. The rest of the paper is organized as fol-
lows: Section 2 discusses the data search, selection and abstraction
approaches for the survey; Section 3 elaborates the various ﬁnd-
ings of the survey, including summaries of all the studies that
met the inclusion criteria; ﬁnally, Section 4 summarizes the main
ﬁndings from Section 3, and concludes the paper by proposing a
possible framework for the development and evaluation of social
media based ADR monitoring systems using publicly available
resources.2. Methods
2.1. Data search and selection
Pharmacovigilance using electronic data is a relatively recent
research topic, and the use of social media data has only started
receiving signiﬁcant research attention in the last few years. As
such, when collecting data, we searched for articles published in
the last ten years only. We searched the databases Medline and
Embase, and also the citation databases Scopus and Web of
Science. We obtained relevant citations from the Medline and
Embase databases by using the advanced search options. When
searching, besides enforcing the constraint associated with the
year of publication, we added several keyword-based constraints.
To summarize, we attempted to obtain publications that contain
indications of ADR detection or Pharmacovigilance AND social net-
works, social media, online forums, online health communities ormes-
sage boards. Fig. 1 presents some example search queries that we
used for searching Medline (using the PubMed3 interface). Since
ADR detection from social media generally involves the use of natu-
ral language processing (NLP), computational linguistics or text min-
ing techniques, we suspected that there could also be publications in
the computer science literature and the publication venues for such
articles may not be indexed in the abovementioned databases. We
therefore searched Google Scholar using the same keywords to
identify publications that may not have been indexed in the more
medical focused databases such as Medline.
For all the search engines, we sorted our search results by rele-
vance. We ﬁltered a total of thirty-nine publications for manual
review and obtained their full texts. We added articles to this list
if their titles or abstracts suggested that the investigators utilized
data from social media for detecting ADRs or for monitoring drug
safety in general. Studies that met our inclusion criteria were those
that presented original data, utilized any internet-based resource
of consumer generated data (e.g., forums, message boards, social
Fig. 1. Sample search queries used for article retrieval from Medline.
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detection (e.g., NLP techniques, and/or other rule-based or machine
learning approaches). In our initial shortlist, we included studies
for which we could not determine if the data in the internet-based
resource consisted of user posts, or if we could not immediately
determine whether the detection algorithms and analyses were
automatic or manual. Our exclusion criteria included studies that
utilized clinical records, laboratory, pharmacy, radiology, or
administrative reports. Studies were also excluded if they focused
exclusively on drug-drug interactions, detected ADRs in
randomized controlled trials, drug labels, or were not published
in English.2.2. Data abstraction
For all included studies, we abstracted data on study character-
istics including study size, research aim(s), primary ADR identiﬁca-
tion/extraction approach, data source, availability of data, and the
type of evaluation performed. For the study size factor, we focused
on two aspects—size of data and number of drugs. We also
attempted to categorize if the study focused on a speciﬁc sub-
domain of drugs (e.g., diabetes) or included a more general set of
drugs. Classifying the primary identiﬁcation/extraction technique
was slightly more challenging because some articles describe the
whole pipeline—from data collection to ADR detection. For these
studies, we focused on the general approach that was employed
at the ﬁnal stage of detection. For example, we found that a num-
ber of techniques relied on ADR lexicons, while another set of tech-
niques relied on detecting linguistic patterns for the ADR detection
task.
For the data source factor, we categorized approaches based on
the social network or type of social media from which the data was
extracted. In terms of availability of data, we categorized studies
based on whether the data used for the study were publicly avail-
able for research purposes or not. Furthermore, we also abstracted
studies based on whether they utilized annotated data, which may
be utilized for supervised machine learning, and is invariably more
useful than unannotated data. Finally, we categorized articles
based on the type of evaluation performed to assess performance.
At a high-level, this included determining if the studies presented
qualitative or quantitative evaluations. For quantitative evalua-
tions, we further categorized on the speciﬁc evaluation approaches
used.3. Results
In this section, we provide details of our methodical survey of
the literature. We ﬁrst present a summary of the data collection
process. Following that, we summarize our review of the selected
literature using the criteria mentioned in the previous section.
We elaborate on the studies in Section 4.3.1. Data collection results
Our data search using the various search engines resulted in
more than 1500 citations, of which thirty-nine articles that
appeared to meet our inclusion criteria based on the title and
abstract information were retrieved and reviewed in full. The large
number of false positives in the initial retrieval process consisted of
a variety of topics including research on social media (e.g., trust
and security), NLP approaches for social media mining but not
pharmacovigilance, and pharmacovigilance studies focusing on
non-social media data. We excluded articles for the various reasons
mentioned in the previous section. Our ﬁnal set consisted of
twenty-two publications, which describe automatic methods for
ADR detection from user posted data on social media. This set con-
sists of journal articles, and conference and workshop proceedings.
The earliest, pioneering work we identiﬁed was from 2010 [17],
which employs a lexicon-based approach and manually annotated
data for evaluation. Following this work, this research topic has
received more attention with three publications in the years
2011 and 2012, four in 2013, and eleven in 2014.3.2. Dimensions of characterization
We now present two tables summarizing some of the key infor-
mation associated with the studies that we reviewed. In addition,
we present some statistics and explanations regarding the contents
shown in the table.
Table 1 summarizes crucial characteristics of the studies. In
addition to the publication years, it shows the data sources, sub-
domains of focus (if any), number of drugs involved in the studies,
the sizes of the data used, and annotations and availability of the
data. The table illustrates some key information regarding what
pharmacovigilance using social media research has covered over
the last 5 years, and how research has evolved. The study by
Leaman et al. [17] utilized data from the health related social
Table 1
Articles published on social media mining for ADR detection, their years of publication, data sources, domains of focus, numbers of drugs, size of data, and annotations and public
availability of the data.
Study Year Source Sub-
domain
# Drugs # Instances Annotations/
available
Leaman et al. [17] 2010 DailyStrength [13] – 6 3600 Yes/No
Nikfarjam and
Gonzalez [34]
2011 DailyStrength [13] – 4 1200 Yes/No
Chee et al. [40] 2011 Yahoo! groups – 435 1,200,000 No/No
Benton et al. [42] 2011 various forumsa Breast
cancer
4 1,100,000 No/No
Hadzi-Puric and
Grmusa [43]
2012 Eight parenting forums Pediatrics 9 1290 Yes/No
Yang et al. [44] 2012 MedHelp [14] – 10* 6244b No/No
Bian et al. [45] 2012 Twitter Cancer 5 2,000,000,000 No/No
Liu and Chen [46] 2013 American Diabetes Association [47] Diabetes – 1,348,364 No/Noc
Yang et al. [48] 2013 Yahoo! groups – 2 6400 Yes/No
Jiang and Zheng [49] 2013 Twitter – 5 885 Yes/No
Yates and Goharian
[50]
2013 AskAPatient [51], Drugs.com [52], Dru-
gRatingZ [53]
Breast
cancer
5 2500d Yes/Yes
Yeleswarapu et al.e
[54]
2014 PatientsLikeMe [55], DailyStrength [13],
MediGuard [56]
– 12f 13,500g No/No
Freifeld et al. [57] 2014 Twitter – 23 60,000 No/No
Segura-Bedmar et al.
[58]
2014 ForumClinic [59] – 187h 400 Yes/Yes
Ginn et al. [38] 2014 Twitter – 74 10,822 Yes/Yes
Liu et al. [60] 2014 MedHelp [14] Heart
disease
– 600 Yes/No
Patki et al. [39] 2014 DailyStrength – 38 10,617 Yes/No
O’Connor et al. [35] 2014 Twitter – 54 1873 Yes/Yes
Yang et al. [61] 2014 MedHelp [14] – 10* – No/No
Sampathkumar et al.
[62]
2014 Medications.com [63], SteadyHealth [64] – – 2000 Yes/No
Sarker and Gonzalezi
[41]
2014 Twitter, DailyStrength [13] – 74 for Twitter, 56 for
DailyStrength
10,822 for Twitter, 10,617 for
DailyStrength
Yes/Yes
Nikfarjam et al. [65] 2014 Twitter, DailyStrength [13] – 81 6279 for DailyStrength, 1784
for Twitter
Yes/Yes
* Only 5 ADRs were included in the study.
a The following social media sites were involved: breastcancer.org, komen.org, csn.cancer.org, bcsupport.org, healthboards.com, cancercompass.com, webmd.com, dai-
lystrength.org, revolutionhealth.com, ehealthforum.com, oprah.com.
b This is the number of threads included, not the number of comments.
c Only 200 comments are annotated for evaluation.
d Only 10% of this data is annotated.
e Study also includes data from AERS and Medline.
f Includes 6 drugs from Leaman et al.
g This is the data that is obtained from the three sources mentioned. The study utilized additional non-social media data.
h Not unique drugs. The number of unique drugs is not mentioned.
i Study also includes a corpus from outside social media.
4 ir.cs.georgetown.edu/data/adr/. Accessed on 06/12/2014.
5 http://labda.inf.uc3m.es/doku.php?id=en:labda_spanishadrcorpus. Accessed on
04/12/2014.
6 diego.asu.edu/downloads/. Accessed on 06/12/2014.
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The number of drugs studied, however, was only six. Table 1 sug-
gests that DailyStrength is a relatively popular source of health-re-
lated user posted data, and it is used by six studies in total. The
table also suggests that early, exploratory research generally
focused on a small number of drugs for ADR investigation. Prior
to 2014, there is only one study that involved more than ten drugs
for investigation. Very recent studies, tend to go beyond investigat-
ing ADRs associated with a small set of drugs, as depicted by the
last few studies in the table. Furthermore, while some studies
focused on speciﬁc domains of drugs (e.g., breast cancer, diabetes,
etc.), most studies, particularly very recent ones, tend to concen-
trate on a range of drugs not speciﬁc to a domain.
In terms of data sizes, the studies presented in Table 1 can be
divided into two important categories—large data sets without
any expert annotations, and relatively small data sets which con-
tain expert annotations. Among the twenty-two publications
included in this review, fourteen (64%) utilized expert annotated
data and eight did not. Among the ﬁfteen papers published since
2013, eleven (73%) exploit annotated data. The table suggests that
there is an increasing trend towards the use of annotated data for
ADR detection. Some of the studies [40,42,45,46] utilize very large
volumes of data and derive statistics via unsupervised techniques.In contrast, studies that rely on annotated data, are capable of
applying supervised approaches and also evaluation against gold-
standards prepared by human experts. However, the public avail-
ability of annotated data is still a concern. We only found four data
sets that have been made publicly available [50,58,38,35,41,65], all
of them published since 2013. The data set4 released by Yates and
Goharian [50] contains only 247 posts containing ADRs. The data
set5 released by Segura-Bedmar et al. [58] contains only 400 posts
in Spanish. The latter data set, therefore, is unlikely to be suitable
for future research tasks in English, but is the ﬁrst of its kind in lan-
guages other than English. These data sets contain binary annota-
tions only, and are also quite small, meaning that their use in
supervised learning technique is likely to be minimal. The data
set6 discussed in [38,35] contains only binary annotations indicating
whether a Twitter post contains an ADR or not, and includes over
7000 instances (70% of the full set used in the study). While this data
set, as published, is not suitable for supervised extraction of ADRs
from text, it is suitable for training algorithms to detect ADR
Table 2
A summary table showing primary ADR detection approaches and evaluation methodologies.
Study Research aim Primary approach(es) Evaluation methodology
Leaman et al.
[17]
Concept/relation extraction Lexicon-based (450 comments for system
development)
Quantitative. Against manually annotated data (3150
instances)
Nikfarjam and
Gonzalez
[34]
Concept/relation extraction Lexical pattern-matching (2400 comments for pattern
building). Association rule mining to identify patterns
Quantitative. Against manually annotated data (1200
instances)
Chee et al. [40] Drug classiﬁcation Ensemble classiﬁcation using drug categories as classes Mixed. Classiﬁcation results are combined to generate
drug scores for 3 drugs, which are compared against
scores for drugs (12) with known adverse effects
Benton et al.
[42]
Concept/relation extraction Lexicon-based. Association rule mining to identify
drug-reaction pairs
Quantitative. Adverse reactions associated with drugs
obtained from product labels and compared against
system reported adverse events
Hadzi-Puric and
Grmusa [43]
Concept/relation extraction Lexicon-based approach for ADR detection. Statistical
scoring for identifying drug-relation associations
Mixed. Qualitative analysis of identiﬁed ADRs against
known ADRs. Recall, precision and F-score computed
for evaluation against annotated data
Yang et al. [44] Concept/relation extraction Lexicon-based. Association rule mining to identify
drug-reaction pairs
Quantitative. FDA AERS used as the gold standard. Lift,
Leverage, and Proportional Reporting Ratio used as
metrics
Bian et al. [45] ADR classiﬁcation Classiﬁcation of tweets using Support Vector Machine
(SVM) classiﬁers. Two classiﬁers built: one to predict if
a user has used a drug (based on the tweets), and the
second to classify if a post contains an adverse effect
Mixed. Evaluation and training is performed on the
same data. Only classiﬁcation accuracies reported.
Analysis describes the limitations introduced by noise
in Twitter
Liu and Chen
[46]
Concept/relation extraction Lexicon-based approach for ADR and drug detection.
Shortest dependency path based machine learning
algorithm for relation extraction
Quantitative. Separate evaluations for entity extraction,
ADR detection and classiﬁcation of patient experiences
using 200 manually annotated comments
Yang et al. [48] ADR classiﬁcation A combination of supervised and unsupervised
approaches for training binary classiﬁers. A mixture of
syntactic, semantic, and sentiment features are used to
train SVM and Naïve Bayes classiﬁers
Quantitative. Evaluation performed on 1600 annotated
instances. Evaluation demonstrates that the
combination of supervised and unsupervised training
performs signiﬁcantly better than using supervised
training only
Jiang and Zheng
[49]
Concept/relation extraction
and classiﬁcation
Supervised classiﬁcation of tweets using a Maximum
Entropy classiﬁer trained on a data set of 600 tweets
only. MetaMap [67] to identify drug and ADR categories
Mixed. 285 tweets for testing the classiﬁcation
accuracy. ADR extraction accuracy is evaluated against
known adverse reactions
Yates and
Goharian
[50]
Concept/relation extraction Pattern-based. 7 patterns used for extracting ADRs from
approximately 125 manually annotated comments
Quantitative. Against manually annotated data (125
instances)
Yeleswarapu
et al. [54]
Concept/relation extraction Lexicon-based. Prepared lexicon used for drug and ADR
detection. Association rule mining and BCPNN used for
identifying drug-symptom and drug-disease pairs
Qualitative. Evaluation is performed via comparative
analysis with ﬁndings from previous studies. Primary
conclusion of evaluation is that combining social media
data with other sources such as medical literature and
ADR databases can improve ADR detection performance
Freifeld et al.
[57]
Concept/relation extraction Lexicon-based. A prepared lexicon is used to detect
ADRs. Aggregated frequencies are used to compare
drug-reaction pairs
Quantitative. Aggregated frequency of identiﬁed
product-event pairs compared with data from AERS.
Correlation between the two sources computed to
assess the effectiveness of social media as a resource for
ADR monitoring
Segura-Bedmar
et al. [58]
Concept/relation extraction Lexicon-based. A prepared lexicon was used in a multi-
lingual text analysis engine to detect drugs and ADRs in
text
Quantitative. Against manually annotated data (400
instances). Drug and ADR detection evaluated
separately
Ginn et al. [38] Corpus presentation/
description. Supervised
learning experiments to
illustrate utility of corpus
Supervised classiﬁcation of ADR assertive tweets using
10-fold cross validation over a large annotated data set
of 10,822 tweets. Data set artiﬁcially balanced to lower
ADR-noADR class imbalance
Quantitative. Evaluated against annotated data on the
artiﬁcially balanced data set
Liu et al. [60] Medical entity extraction,
adverse event extraction,
report source classiﬁcation
Lexicon-based approach for entity extraction and ADR
extraction. Rule-based approach for relation
classiﬁcation
Quantitative. Against manually annotated data (600).
Same set of instances used for the tasks of events and
treatments recognition, ADR identiﬁcation, and patient
report extraction
Patki et al. [39] ADR/drug classiﬁcation Supervised classiﬁcation of ADR assertive comments
using SVMs and a rich set of features extracted via NLP
techniques. Probabilities of all comments associated
with each drug combined to predict if drug should be
categorized as normal or blackbox
Mixed. Annotated data used for evaluating the
classiﬁcation task. Accuracy values used for evaluating
drug categorization strategy
O’Connor et al.
[35]
Concept/relation extraction Lexicon-based approach for detecting ADR mentions in
Twitter data. Lexicon created by combining several
existing ADR lexicons
Quantitative. Against manually annotated data (1873
instances)
Yang et al. [61] Drug-ADR relation extraction Lexicon-based approach for detecting ADR mentions.
Association rule mining to identify relationships
between drugs and ADRs
Quantitative. Lift and Proportional Reporting Ratio for
scoring association of ADRs with drugs. Recall, precision
and F-measure used to compare the performance
against three publicly available systemsa
Sampathkumar
et al. [62]
Concept/relation extraction
and relationship (causal)
identiﬁcation
Lexicon-based approach for detecting mentions of
ADRs. Hidden Markov Model applied to detect
relationship between drug-ADR pairs
Mixed. 10-fold cross validation against manually
annotated data (2000 instances). Extracted ADRs
compared against drug package labels to verify
performance and to identify unknown ADRs
Sarker and
Gonzalez
ADR classiﬁcation Supervised classiﬁcation to detect ADR assertive texts.
Features incorporated from distinct research areas such
Quantitative. F-score for the ADR class is computed
against gold standard annotations
(continued on next page)
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Table 2 (continued)
Study Research aim Primary approach(es) Evaluation methodology
[41] as sentiment analysis, polarity classiﬁcation and topic
modeling. Multiple corpora combined to boost
classiﬁcation performance
Nikfarjam et al.
[65]
Concept/relation extraction Concept extraction is performed using supervised
learning via conditional random ﬁelds (CRF). Word
clusters, learnt from large unlabeled data, are used as
features
Quantitative. Against manually annotated data (1559
and 444 instances for two data sources)
a The three systems are: Treato.com, sideeffective.com, and AdverseEvents.com.
9 http://www.consumerhealthvocab.org/. Accessed 06/16/2014.
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outside of social media [66], and will be crucial to explore within this
domain as well. In a more recent publication, span and concept nor-
malization annotations for the same data set, containing over 1500
instances, have been released to the public [65], and this data set
can be utilized for ADR extraction tasks.
Table 2 provides a brief summary of the ADR detection/extrac-
tion approaches proposed by the studies, their primary research
aims, and how the evaluations were designed. Note that in this
context, ADR refers to adverse reactions only, as well as drug and
adverse reaction pairs. The table follows on from the information
provided in Table 1, and enables us to achieve an understanding
of the success of different classes of approaches for ADR detec-
tion/extraction problems. The table illustrates that two of the most
frequently addressed problems have been the detection of com-
ments/sentences discussing ADRs, and the extraction of speciﬁc
ADRs from sentences. This suggests that these two problems are
perhaps the most important for systems attempting to propose
end-to-end pharmacovigilance solutions. The evaluation
approaches, however, vary more between systems. When anno-
tated data is available, generally standard measures such as
Recall, Precision and F-score are used. In the absence of annotated
data, evaluation approaches and metrics tend to be varied. Later
in this section, we discuss some of the evaluation methodologies
mentioned in Table 2.
3.3. A summary of methodologies and resources
3.3.1. Lexicons and knowledge bases
Our survey revealed that ADR lexicons and knowledge bases
have been the most widely used resource for pharmacovigilance
techniques from social media. These resources contain lists of
ADR mentions, collected from various sources ranging from drug
labels, clinical trials, caregivers, and even user posts on social
media. Signiﬁcant efforts have been made for the creation of new
knowledge sources and the combination of existing ones. From
the studies that utilized lexicons, we have compiled a list of
resources containing ADR mentions, which is as follows:
1. FDA AERS.7 This is the FDA adverse event reporting system and
database that is designed to support FDA’s post-marketing
surveillance of drugs. Healthcare professionals and consumers
voluntarily report adverse reactions to this system. This database
has been widely used for pharmacovigilance research, including
those involving social media [42,46,54,57,60].
2. COSTART8 (Coding Symbols for a Thesaurus of Adverse Reaction
Terms). This resource is used for coding, ﬁling, and retrieving
post-marketing ADRs. It is organized in a hierarchical
structure. This resource contained a total of 3787 ADRs, and has
been superseded by MedDRA. Used by: [17,34].7 http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveil-
lance/AdverseDrugEffects/default.htm Accessed on 06/16/2014.
8 http://bioportal.bioontology.org/ontologies/COSTART. Accessed: 06/13/2014.3. CHV9 (Consumer Health Vocabulary). This database was
created as an initiative to map words and phrases representing
ADRs from lay persons to technical terms used by health
professionals. Since this resource contains terms and phrases
used by non-experts, it has become a very useful for
pharmacovigilance research using social media data
[42,46,60,61].
4. MedEffect.10 MedEffect Canada provides consumers, health
professionals and patients with access to adverse drug reaction
reporting, obtain safety information, and learn and better
understand the importance of reporting side effects. The adverse
reaction database contains reports of suspected adverse drug
reactions. Used by: [17].
5. UMLS11 (Uniﬁed Medical Language System). UMLS is a broad
meta-thesaurus containing a large collection of biomedical
vocabulary. It categorizes medical terms into broad and ﬁne-
grained categories, and these categorizations have been used to
detect mentions of ADRs [46].
6. MedDRA12 (Medical Dictionary for Regulatory Activities). This is
a rich, highly speciﬁc, multilingual, standardized medical
terminology to facilitate sharing of regulatory information
internationally for medical products. It has also been a popular
resource for building lexicons for ADR detection [40,54,57].
7. SIDER13 (Side Effect Resource). This is a knowledge base that uses
MedDRA and contains ADR information on marketed medicines
from public documents and package inserts. The resource con-
tains a total of 4192 ADRs associated with 996 drugs. Used
by: [17,34,62].
3.3.2. Automatic classiﬁcation of ADR containing user posts
A number of the studies we reviewed focus on the automatic
classiﬁcation of user posts to determine if ADRs are mentioned in
the posts [40,45,48,49,38,41]. The motivation for such classiﬁca-
tion approaches arises from the fact that most drug related posts
on social media are not associated with ADRs, and thus, ﬁltering
out irrelevant posts is crucial. Supervised classiﬁcation approaches
require manually annotated data, and large numbers of annotated
posts are required to make reliable evaluations. The preparation of
large, annotated data sets (e.g., the data set described in [38,41]),
will be essential for advancing this task.
Some research attempted to perform supervised classiﬁcation
of drugs directly into broad categories using the comments associ-
ated with them for training (e.g., [40]). Very small training data
have also been applied (e.g., [45]) with common machine learning
algorithms such as Naïve Bayes, Support Vector Machines and
Maximum Entropy. One important challenge that has been con-
stantly discussed in supervised learning tasks is the data imbalance0 http://www.hc-sc.gc.ca/dhp-mps/medeff/index-eng.php. Accessed on 06/13/
014.
1 http://www.nlm.nih.gov/research/umls/. Accessed 06/16/2014.
2 http://www.meddra.org/. Accessed 06/16/2014.
3 http://sideeffects.embl.de/. Accessed: 06/13/2014.1
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Table 3
Comparison of system recalls, precisions and F-scores for ADR extraction when
manually annotated data is used for evaluation.
Study Size Recall Precision F-score
Leaman et al. [17]a 3150 0.70 0.78 0.74
Nikfarjam and Gonzaleza [34] 1200 0.66 0.70 0.68
Hadzi-Puric and Grmusa [43] 990 0.65 0.75 0.70
Liu and Chen [46] 200 0.80 0.87 0.84
Yates and Goharian [50] 125 0.89 0.69 0.78
Freifeld et al. [57] 437 0.86 0.72 0.78
Segura-Bedmar et al. [58] 400 0.56 0.85 0.68
O’Connor et al. [35] 1873 0.62 0.54 0.58
Sampathkumar et al. [62] 2000 0.74 0.79 0.76
Nikfarjam et al. (DailyStrength) [65] 1559 0.78 0.86 0.82
Nikfarjam et al. (Twitter) [65] 444 0.68 0.77 0.72
a Systems using the same (or subsets of the same) data set.
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uses the largest annotated data set from a generic social media
website (Twitter), suggests that only a very small amount of drug
related posts contain ADRs (approximately 10%). Recent annota-
tion work on health-related social networks [39] suggests that
the proportion of ADR associated information in such networks is
higher (approximately 20–25%). However, this imbalance is still a
challenge from the perspective of machine learning, and this prob-
lem has been addressed in detail in recent research [41]. In the
mentioned study, the authors employed a number of strategies
including the use of weighted classiﬁers, incorporation of features
from other text classiﬁcation problems, and the combination of
multiple corpora for training.14 For evaluation approaches applying a mixture of quantitative and qualitative
evaluations, we categorize them into one of the categories based on the primary
evaluation ideology.
15 Drugs containing boxed warnings regarding ADRs.3.3.3. ADR mention extraction
A majority of the papers that met our inclusion criteria focused
on identifying speciﬁc ADR mentions from user posts and extract-
ing them. About half of the approaches (55%) mentioned in Table 2
are lexicon-based, meaning that their primary technique is to
identify ADRs using a list of precompiled ADR mentions
[17,42,44,46,54,57,58,35,61,62]. Considering the availability of
several extensive ADR resources, applying lexicon-based NLP tech-
niques can successfully identify a subset of the ADR mentions in
user posts. However, pure lexicon-based approaches do not
address some important challenges. Consumers do not always
use technical terms found in the existing lexicons. Instead, they
use creative phrases, descriptive symptom explanations, and idio-
matic expressions. For example, the phrase ‘messed up my sleeping
patterns’ was used to report the ADR ‘sleep disturbance’ in the data
set made available by [38,35]. Even when a mention in a user sen-
tence is matched with a lexicon term, it is not necessarily an
adverse effect. The terms used to describe ADRs can also be used
for indications, beneﬁcial effects, or other mention types. Finally,
the various properties of user generated text mentioned earlier
(e.g., misspellings, abbreviations, and phrase construction irregu-
larities) limit the performance of lexicon-based approaches.
In addition to extracting ADR mentions, some studies have
focused on identifying the relations between ADRs and drugs.
Following the study by Nikfarjam and Gonzalez [34], a popular
approach for the discovery of drug-ADR pairs, in lexicon-based
and other techniques, has been the use of association rule mining
[68]—a class of techniques by which associations between entities
are discovered. In general, following the identiﬁcation of ADRs and
drugs, association rule mining is used to identify if a drug and ADR
pair is associated or not. Frequent occurrence of drug-ADR pair
mentions in close proximity within user posts are considered to
be indications of ADRs associated with the drugs, and these
associations are detected by association rule mining in unanno-
tated data.While most approaches use lexicons for detecting drug and ADR
mentions in text, some attempt to discover patterns in texts which
are likely to be indicative of ADRs [34,50]. An advantage of pattern-
based approaches over lexicon-based approaches is that they are
capable of detecting inexact matches. This is particularly useful
for mining social media where users frequently use colloquial
terms and the texts contain misspellings. The hypothesis behind
using pattern-based approaches for social media mining is that,
although users tend to use highly informal language, there are
some converging patterns, which can be used to detect ADR men-
tions. One of the main drawbacks of such approaches, however, is
the need for very large amounts of data for the generation of pat-
terns. With the generation of annotated data in recent times,
supervised learning approaches are becoming increasingly
popular, and they have also shown promising performances in
quantitative evaluations [62,65].
3.4. A summary of evaluation techniques and metrics
Our review of the approaches for ADR detection/extraction
techniques from social media suggests that despite the increasing
interest in this research area, a common evaluation approach that
can be applied across systems is still absent. This is primarily due
to the absence of common data sets which can be utilized for per-
forming comparative evaluations of systems. As such, research
tasks generally design their own evaluation approaches, and either
propose new evaluation techniques or use existing evaluation
techniques compatible with their proposed approaches. We now
brieﬂy discuss some of the evaluation approaches that have been
applied. We group them into two broad categories: Qualitative
and Quantitative.14
3.4.1. Qualitative evaluation
The end goal of ADR detection from social media sources is to be
able to identify drugs that are either frequently related to ADRs or
those that are associated with serious ADRs. Therefore, some
research has focused on devising strategies for computing scores
for drugs, with known ADRs, based on various criteria, and perform
the ﬁnal evaluation in a qualitative manner. For example, Chee
et al. [40] use an ensemble classiﬁcation approach to classify drugs
into two predetermined categories: watchlist and normal.
Following this, a score is computed based on the number of times
a drug is classiﬁed as watchlist, and the scores are compared to
drugs already withdrawn from the market for associated ADRs.
The ﬁnal evaluation is qualitative, with a comparison of the scores
obtained by withdrawn drugs and some watchlist drugs, which,
according to the authors should be scrutinized. Similar qualitative
discussions accompany quantitative analyses in [45,49,39]. Patki
et al. [39] utilize supervised machine learning to classify comments
associated with drugs belonging to two categories blackbox15 and
normal. For evaluation, the authors combine the classiﬁcation proba-
bilities of comments associated with each drug and suggest that the
combined probabilities may act as indicators for the detection of
drugs containing important ADRs. The evaluation, however, is not
fully quantitative, and primarily compares and discusses the reasons
for misclassiﬁed drugs.
3.4.2. Quantitative evaluation
As already mentioned, comparing all the different systems that
have been reviewed in this paper is not possible, since most
research tasks utilized in-house data that have not been made
Fig. 2. A framework for ADR detection and extraction from social media data.
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been designed such that evaluations could be performed using
existing metrics such as Recall, Precision, F-score and Accuracy
[17,34,42,43,45,46,50,57,58,38,39,41,62,65]. In the absence of
manually annotated data, these metrics have been computed using
various gold standards, such as known adverse reactions from FDA
product labels [42] or databases [44,57]. We found ten studies that
used manually annotated data for the evaluation of the drug-ADR
extraction task. Table 3 presents the results, and illustrates the dif-
ﬁculty of comparing the various systems because of the use of dif-
ferent data sets of varying sizes. Considering the small amount of
annotated data based on which most of these systems were built,
it is likely that the overall performances will improve as more
annotated data become available. Other metrics for quantitative
evaluations have also been used, though less frequently. They
include: lift, leverage, proportional reporting ratio [44]; andmatching
rate [49].4. Discussion and conclusions
Our survey covers research efforts for automatic pharmacovigi-
lance techniques from social media data. The review includes care-
fully selected articles, published over the last four years, starting
with the pioneering work of Leaman et al. [17]. The studies
included in the survey show the growing attention that the utiliza-
tion of social media data is receiving. Moreover, while early
research tasks have been mostly exploratory, recent approaches
have illustrated the need and interest for structured standardized
approaches and annotated data. All but six studies in our sample
used data that is publicly unavailable for system development
and evaluation. As such, at this point, performing a direct compar-
ison of existing detection/extraction approaches is impossible. At
the same time, evaluations of systems have also progressed in vari-
ous directions, without the development of any standard evalua-
tion criteria. A transition in research methodologies is however
clearly visible, as large annotated data sets are gradually becoming
available.
Most extraction approaches relied on using lexicons for
identifying/extracting ADR mentions in text, while pattern-match-
ing-based approaches have also been applied. Lexicon-based
approaches face speciﬁc obstacles when applied to social media
data, whereas pattern-based methods require large amounts of
data for system development. Only recently, there has been a trend
in supervised learning approaches that attempt to utilize anno-
tated data, and it is likely that comprehensive supervised classiﬁ-
cation approaches will be used more frequently in the near future.4.1. A framework for ADR detection and extraction from social media
data
Building on this review, we propose a possible framework for
future ADR detection efforts from social media. Considering the
recent developments of annotated data and large-scale annotation
efforts, much of future research will invariably attempt to utilize
supervised learning approaches. In the proposed framework, we
only referred to data that is publicly available for performing
ADR detection from social media. Fig. 2 presents a high level illus-
tration of the framework.
The ﬁrst step in working with social media data is the collection
of the data. All the papers discussed in this review perform data
collection from various sources. For health related social networks,
such as Dailystrength, the collection of relevant data is generally
easy since the data is categorized according to various criteria
(e.g., drug name). For generic social networks, such as Twitter,
the collection problem is harder. It is possible to collect posts by
using drug names as search keywords, but drug names are often
misspelt by users. To address this problem recent research
[38,35] has utilized phonetic spelling ﬁlters to generate common
misspellings for drug names [69]. These recent advances in NLP
will aid future data collection processes.
Following data collection, the challenge is to ﬁlter data. As
explained earlier, data imbalance is an important problem in
ADR mining from social media text, which has resulted in various
research tasks on classiﬁcation of ADR assertive text [49,48,38,39].
With the creation of recent publicly available corpora (e.g.,
[50,38,35,58], learning algorithms can be trained and optimized
to detect ADR assertive instances with high accuracies. Most clas-
siﬁcation research, however, have only used very basic linguistic
features for classiﬁcation (e.g., bag of words), and only very recent
research has focused on exploring deep linguistic and semantic
features and advanced machine learning techniques [41].
Effective ﬁltering/classiﬁcation techniques are likely to aid the
process of ADR mention extraction by removing the majority of
irrelevant information. We have discussed various ADR extraction
approaches in the paper, the most popular being lexicon-based
ones. Lexicon-based approaches have beneﬁted from recent expan-
sions and merging of existing lexicons, and the incorporation of
colloquial terms. Recent release of publicly available annotated
data [65] will inevitably popularize supervised learning
approaches for this task.
The last step in the pipeline is to perform statistical analysis on
extracted drug-ADR pairs to identify potentially harmful drugs.
This step has hardly received any research attention to date, and
we only identiﬁed two exploratory studies attempting to perform
A. Sarker et al. / Journal of Biomedical Informatics 54 (2015) 202–212 211this task on social media data [40,39]. Progress in ADR extraction
and classiﬁcation research is likely to raise the research focus on
the analysis of drug-ADR signals generated from social media data.
Considering the rapid growth of social media data, this source of
information is likely to have a massive impact on pharmacovigi-
lance research.Acknowledgement
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